Below is the information acquired on FRESENIUS SE & CO. KGAA, which is not yet included in our research perimeter.

To request an evaluation of this company and its inclusion in the OpenCorporation Ranking or if you have additional, different and more updated data than what is published in this OpenCorporation company card, please write to info@opencorporation.org so that our team may take it in account.

Last update 22 March 2021

Description of economic activities

Manufacture of medical and dental instruments and supplies (NACE2 3250)

This company, formerly known as Fresenius AG, is engaged in providing a broad range of innovative healthcare products and services. It was founded in 1912 by Dr. Eduard Fresenius under the name Dr. E. Fresenius. The registered head office of the company is located in Bad Homburg, Germany. The company operates through its five business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Fresenius Biotech. The Fresenius Medical Care unit specialises in supplying medical equipment and devices for hemodialysis, acute dialysis, peritoneal dialysis, dialysis care, spectra laboratories, liver support therapy, and therapeutical apheresis. Its Fresenius Kabi business offers a variety of products for infusion therapy and clinical nutrition, including oncology drugs, anaesthetics, analgesics, and anti-infectives; syringe pumps and volumetric pumps; and cell separators, autotransfusion devices, and blood bag systems. The Fresenius Helios segment is involved in the management and operation of acute care hospitals, and post-acute care hospitals in Germany. The Fresenius Vamed business provides a comprehensive range of services for hospitals and other health care facilities, including feasibility studies, operational and organisational planning, it planning, medical-technical maintenance, building technology planning, and turn-key projects. The Fresenius Biotech unit is dedicated to delivering innovative therapeutics to patients with serious illnesses that have a high degree of unmet need. The company employs more than 130,000 people. It also operates in Italy, Spain, France, United Kingdom, Austria, Switzerland, Netherlands, Belgium, Norway, Sweden, Poland, Canada, Mexico, Brazil, China, Korea, India, South Africa, Portugal and the Czech Republic.
  • FRESENIUS SE & CO. KGAA

  • Germany (DE)
  • Company type: Corporate
  • Parent company: N/A
  • Chief Executive Officer (CEO): Dr. Gerd Edgar Krick
  • CEO Total remuneration: N/A
  • Website: www.fresenius.de

Financial data

Number of employees

N/A
294,134
276,750
273,249

Revenue 1

N/A
35.869
34.78
34.279

EBIT 1

N/A
4.631
5.251
4.589

EBITDA 1

N/A
6.188
6.681
6.026

1 numbers are in millions

  • RepRisk Indicator (last month):  40

Social dialog

  • Transnational Corporate Agreement (TCA): N/A
  • Global Framework Agreement (GFA): N/A
  • Societas Europaea (SE):
  • Bangladesh Accord: N/A

European Works Councils

Standards and certifications

  • Global Compact: N/A
  • CDP (Carbon Disclosure Project): N/A
  • Modern Slavery Statement: N/A
  • Transparency Index: N/A
  • SA8000 Social Accountability: N/A
  • Integrated report: N/A
  • ISO26000: N/A
  • OECD Guidelines:
  • Social Development Goals (SDGs): N/A

Global Reporting Initiative certification

  • Global Reporting Initiative standards: N/A
  • Global Reporting Initiative GRI G4: N/A

Other company declarations

  • Corporate Social Responsability:
    N/A
  • Accessibility: N/A

Policies

  • Training policy: N/A
  • Policy to protect the right to health and safety in the workplaces where the company operates: N/A
  • Policy to protect the right to health and safety in the workplaces in the supply chain: N/A
  • Diversity policy: N/A

Universal declarations

Declarations and treaties recognised by the country where the company has its registered office

  • Universal Declaration of Human Rights:
  • European Convention on Human Rights (ECHR):
  • Charter of Fundamental Rights of CDFL Workers (Strasbourg Charter 1989):
  • Charter of Fundamental Rights of the European Union EU CFR (Nice Charter 2000):
  • Treaty on the Functioning of the European Union TFEU:
  • Registered office in an OECD country:
  • ILO C029 - Forced Labour Convention, 1930 (No. 29):
  • ILO C087 - Freedom of Association and Protection of the Right to Organise Convention, 1948 (No. 87):
  • ILO C098 - Right to Organise and Collective Bargaining Convention, 1949 (No. 98):
  • ILO C100 - Equal Remuneration Convention, 1951 (No. 100):
  • ILO C105 - Abolition of Forced Labour Convention, 1957 (No. 105):
  • ILO C111 - Discrimination (Employment and Occupation) Convention, 1958 (No. 111):
  • ILO C138 - Minimum Age Convention, 1973 (No. 138):
  • ILO C182 - Worst Forms of Child Labour Convention, 1999 (No. 182):

Directives applied in the company offices in EU 27

  • D. 80/987/EEC:
  • D. 89/391/EEC:
  • D. 98/59/EC:
  • D. 2000/43/EC:
  • D. 2000/78/EC:
  • D. 2001/23/EC:
  • Council D. 2001/86/EC:
  • D. 2002/14/EC:
  • D. 2002/73/EC:
  • Council D. 2003/72/EC:
  • EP and Council D. 2005/56/EC:
  • D. 2009/38/EC:
  • D. 2004/25/EC:
  • D. 2011/35/EU:

Presence in main rankings

  • Global 100 Most Sustainable Corporations: N/A
  • Global CSR Rep Trak 100: N/A
  • BrandZ Top 100 Most Valuable US Brands: N/A
  • The Worlds Best Multinational Workplaces: N/A
  • The Gartner Supply Chain Top 25: N/A
  • The Worlds Most Innovative Companies: N/A
  • The Diversity Inc Top 50 Companies: N/A
  • Best Global Websites: N/A
  • Green Ranking Global Top 500: N/A
  • Green Ranking Global Top 100: N/A